Rhee, Christopher J.
da Costa, Cristine Sortica
Austin, Topun
Brady, Ken M.
Czosnyka, Marek
Lee, Jennifer K.
Article History
Received: 26 January 2018
Revised: 4 June 2018
Accepted: 27 July 2018
First Online: 8 September 2018
Competing interests
: Dr. Brady is listed as a co-inventor of autoregulation monitoring technology that has been licensed to Medtronic Inc. Dr. Czosnyka has a financial interest in a part of the licensing fee for ICM+ software that is licensed by the University of Cambridge, Cambridge Enterprise Ltd. Dr. Lee is a paid advisory board member for Medtronic Inc. Dr. Lee also received a research grant from Medtronic for a separate clinical study on cerebrovascular autoregulation. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. Medtronic did not provide any support (financial or other) or have any input on the current project and manuscript. The remaining authors declare no competing interests.